{
    "id": 26136,
    "fullName": "ESR1 V422del",
    "impact": "deletion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ESR1 (ER alpha) V422del results in the deletion of an amino acid in the steroid-binding and AF-2 transactivation regions of the Esr1 (Er alpha) protein (UniProt.org). V422del results in constitutive activation of Esr1 (Er alpha) in cell culture (PMID: 27986707).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 8160,
                    "pubMedId": 27986707,
                    "title": "Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27986707"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2099,
        "geneSymbol": "ESR1",
        "terms": [
            "ESR1",
            "ER",
            "Era",
            "ESR",
            "ESRA",
            "ESTRR",
            "NR3A1"
        ]
    },
    "variant": "V422del",
    "createDate": "03/08/2017",
    "updateDate": "03/08/2017",
    "referenceTranscriptCoordinates": {
        "id": 112408,
        "transcript": "NM_000125",
        "gDna": "chr6:g.152061020_152061022delTGG",
        "cDna": "c.1265_1267delTGG",
        "protein": "p.V422delV",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10186,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Faslodex (fulvestrant) inhibited ESR1 activity and proliferation of breast cancer cells expressing ESR1 V422del in culture, and inhibited tumor growth in xenograft models (PMID: 27986707).",
            "molecularProfile": {
                "id": 27315,
                "profileName": "ESR1 V422del"
            },
            "therapy": {
                "id": 744,
                "therapyName": "Fulvestrant",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8160,
                    "pubMedId": 27986707,
                    "title": "Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27986707"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10205,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD9496 inhibited growth of breast cancer cells expressing ESR1 V422del in culture, and inhibited tumor growth in xenograft models (PMID: 27986707).",
            "molecularProfile": {
                "id": 27315,
                "profileName": "ESR1 V422del"
            },
            "therapy": {
                "id": 2997,
                "therapyName": "AZD9496",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8160,
                    "pubMedId": 27986707,
                    "title": "Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27986707"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10221,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, RU58668 inhibited growth of breast cancer cells expressing ESR1 V422del in culture (PMID: 27986707).",
            "molecularProfile": {
                "id": 27315,
                "profileName": "ESR1 V422del"
            },
            "therapy": {
                "id": 5424,
                "therapyName": "RU58668",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8160,
                    "pubMedId": 27986707,
                    "title": "Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27986707"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10208,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, GDC-0810 inhibited growth of breast cancer cells expressing ESR1 V422del in culture (PMID: 27986707).",
            "molecularProfile": {
                "id": 27315,
                "profileName": "ESR1 V422del"
            },
            "therapy": {
                "id": 2150,
                "therapyName": "GDC-0810",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8160,
                    "pubMedId": 27986707,
                    "title": "Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27986707"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27315,
            "profileName": "ESR1 V422del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 112397,
            "transcript": "XM_006715374",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112401,
            "transcript": "XM_011535545",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112399,
            "transcript": "XM_017010378",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112396,
            "transcript": "NM_001122742",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112407,
            "transcript": "NM_001122740",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112392,
            "transcript": "XM_017010377",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112403,
            "transcript": "NM_001122741",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112406,
            "transcript": "XM_011535544",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112400,
            "transcript": "XM_017010379",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112405,
            "transcript": "XM_017010381",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112404,
            "transcript": "NM_001291241",
            "gDna": "chr6:g.152061022_152061024delGAG",
            "cDna": "c.1264_1266delGAG",
            "protein": "p.E422delE",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112398,
            "transcript": "XM_011535547",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112408,
            "transcript": "NM_000125",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112395,
            "transcript": "XM_011535543",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112393,
            "transcript": "XM_017010376",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112394,
            "transcript": "XM_017010380",
            "gDna": "chr6:g.152061020_152061022delTGG",
            "cDna": "c.1265_1267delTGG",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112409,
            "transcript": "XM_006715375",
            "gDna": "chr6:g.152098961_152098963delGTC",
            "cDna": "c.1264_1266delGTC",
            "protein": "p.V422delV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 112402,
            "transcript": "NM_001291230",
            "gDna": "chr6:g.152061013_152061015delGGC",
            "cDna": "c.1264_1266delGGC",
            "protein": "p.G422delG",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}